Everolimus tablets for patients with subependymal giant cell astrocytoma
about
The molecular biology of WHO grade I astrocytomasEverolimus in the treatment of subependymal giant cell astrocytomas, angiomyolipomas, and pulmonary and skin lesions associated with tuberous sclerosis complex.Subependymal giant cell astrocytomas in patients with tuberous sclerosis complex: considerations for surgical or pharmacotherapeutic intervention.
P2860
Everolimus tablets for patients with subependymal giant cell astrocytoma
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Everolimus tablets for patients with subependymal giant cell astrocytoma
@en
Everolimus tablets for patients with subependymal giant cell astrocytoma.
@nl
type
label
Everolimus tablets for patients with subependymal giant cell astrocytoma
@en
Everolimus tablets for patients with subependymal giant cell astrocytoma.
@nl
prefLabel
Everolimus tablets for patients with subependymal giant cell astrocytoma
@en
Everolimus tablets for patients with subependymal giant cell astrocytoma.
@nl
P2093
P2860
P50
P1476
Everolimus tablets for patients with subependymal giant cell astrocytoma
@en
P2093
James J Vredenburgh
Katherine B Peters
Scott G Turner
P2860
P304
P356
10.1517/14656566.2011.601742
P407
P577
2011-08-01T00:00:00Z